TABLE 2.
Group | Before intervention | After intervention | Test value/p | ||
---|---|---|---|---|---|
Median (min‐max) | Median (min‐max) | z | p | ||
TSH (uIU/mL) | Control group | 2.51 (1.99–4.60) | 2.56 (2.46–4.40) | −1.07 | .28 |
MD | 1.75 (1.25–2.76) | 2.10 (1.21–2.83) | −0.76 | .44 | |
GFD | 1.26 (1.05–1.76) | 1.47 (1.26–1.90) | −1.17 | .24 | |
MGFD | 1.65 (0.93–3.71) | 1.92 (0.96–3.97) | −1.78 | .07 | |
X 2 = 5.20 p = .16 | X 2 = 8.32 p = .04 Difference = 3 < 1 | ||||
FT3 (pg/mL) | Control group | 2.99 (2.80–3.87) | 3.03 (2.90–3.88) | −1.24 | .21 |
MD | 2.50 (2.45–2.70) | 2.86 (2.78–2.94) | −2.80 | .01 | |
GFD | 2.60 (2.46–2.67) | 2.71 (2.61–2.93) | −2.19 | .03 | |
MGFD | 3.30 (2.98–3.50) | 3.57 (3.21–3.67) | −2.80 | .01 | |
X 2 = 18.76 p = .00 Difference = 2.3 < 1.4 | X 2 = 12.96 p = .00 Difference = 3 < 1.4 | ||||
FT4 (ng/dL) | Control group | 14.06 (0.95–15.80) | 14.50 (0.98–16.60) | −2.70 | .01 |
MD | 0.91 (0.90–0.94) | 0.97 (0.93–0.98) | −2.44 | .01 | |
GFD | 0.97 (0.88–1.04) | 0.99 (0.98–1.28) | −2.09 | .04 | |
MGFD | 1.01 (0.94–1.30) | 1.25 (0.98–1.54) | −2.80 | .01 | |
X 2 = 7,11 p = .07 | X 2 = 8.80 p = .03 | ||||
Anti TPO (IU/mL) | Control group | 61.05 (36.11–76.67) | 59.55 (30.67–76.90) | −1.27 | .20 |
MD | 70.76 (47.88–102.30) | 68.95 (46.32–90.80) | −2.80 | .01 | |
GFD | 150.29 (44.68–267.55) | 133.25 (42.41–247.30) | −2.70 | .01 | |
MGFD | 257.56 (90.30–386.31) | 140.20 (82.40–320.10) | −2.80 | .01 | |
X 2 = 6.97 p = .07 | X 2 = 5.53 p = .14 | ||||
Anti Tg (IU/mL) | Control group | 22.85 (21.44–23.30) | 21.65 (19.80–31.20) | −0.05 | .96 |
MD | 20.00 (8.96–52.37) | 13.74 (6.89–50.80) | −2.80 | .01 | |
GFD | 7.50 (2.05–56.70) | 6.31 (2.03–40.47) | −2.80 | .01 | |
MGFD | 32.66 (19.87–46.50) | 25.77 (15.60–43.20) | −2.80 | .01 | |
X 2 = 4.32 p = .23 | X 2 = 3.50 p = .32 |
Abbreviations: GFD,Gluten‐free diet; MD, Mediterranean diet; MGFD, Mediterranean gluten‐free diet; X 2, Ki square, Krukal Wallis‐H; z,Wilcoxon test.